LAVA Therapeutics
Why Robinhood?
You can watch LVTX and buy or sell other stocks, ETFs, and their options commission-free!About LVTX
LAVA Therapeutics NV is an immuno-oncology company, which engages in the proprietary Gammabody platform to develop a portfolio of bispecific gamma delta T cell engagers for the potential treatment of solid tumors and hematological malignancies. The company was founded by Erik van den Berg in 2016 and is headquartered in Utrecht, the Netherlands.
LVTX Key Statistics
Stock Snapshot
With a market cap of 45.77M, LAVA Therapeutics(LVTX) trades at $1.74. The stock has a price-to-earnings ratio of -2.02.
LAVA Therapeutics(LVTX) stock opened on 2026-05-05 at —. The price climbed to — and dipped to —.
LAVA Therapeutics(LVTX) shares are trading with a volume of 0, against a daily average of 138.76K.
During the past year, LAVA Therapeutics(LVTX) stock moved between $0.85 at its lowest and $2.00 at its peak.
During the past year, LAVA Therapeutics(LVTX) stock moved between $0.85 at its lowest and $2.00 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.